Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

G & W Laboratories Inc. Recalls Single Lot of Migergot (Ergotamine Tartrate and Caffeine Suppositories)
G & W Laboratories Inc. has recalled a single lot of Migergot (Ergotamine Tartrate and Caffeine Suppositories). Lot number 016609002 is being recalled because is being recalled because samples from this lot did not pass the manufacturer's routine tests for impurities and by-products from chemical breakdown over time. Migergot contains the active ingredient Ergotamine Tartrate and Caffeine and is commonly used in the treatment of migraine headache. Ergotamine Tartrate and Caffeine is also sold under other brand names. This recall alert only applies to the single lot of Migergot (Ergotamine Tartrate and Caffeine Suppositories). No other Ergotamine Tartrate and Caffeine products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm281022.htm
Learn More

New FDA Labeling for OTC Pain Relievers Also Applies to Patients Taking Combination Products
The Food and Drug Administration announced it will require manufacturers of over-the-counter (OTC) pain relievers, fever reducers and other cough and cold medications that contain non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (the active ingredient in Advil, Motrin and other Brands), aspirin (Bayer Aspirin and other Brands) and naproxen (the active ingredient in Aleve and other Brands) to revise their labeling to include warnings about potential safety risks, such as internal bleeding, associated with the use of these popular drugs. For more information, please visit: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm153331.htm
Learn More

Date Published Title Drug Source
2011-12-06 G & W Laboratories Inc. Recalls Single Lot of Migergot (Ergotamine Tartrate and Caffeine Suppositories) Caffeine with Ergotamine Tartrate FDA
2009-05-04 New FDA Labeling for OTC Pain Relievers Also Applies to Patients Taking Combination Products FDA
2008-08-13 Heart risks with calcium supplements in healthy post-menopausal women MediGuard CRT
2008-07-03 New Consumer Guide for Patients Calcitonin MediGuard CRT
2010-10-27 Fresenius Recalls Single Lot of PhosLo GelCaps Calcium Acetate FDA
2008-08-13 Heart risks with calcium supplements in healthy post-menopausal women Calcium Ascorbate MediGuard CRT
2008-08-13 Heart risks with calcium supplements in healthy post-menopausal women Calcium Carbonate MediGuard CRT
2010-01-15 Voluntary Recall of Certain Lots of McNeil Over-the-Counter Products Calcium Carbonate with Magnesium Hydroxide Manufacturer
2010-11-24 McNeil Issues Another Recall: Rolaids Extra Strength Softchews Calcium Carbonate with Magnesium Hydroxide Manufacturer
2010-12-10 McNeil Now Recalls All Lots of Three Rolaids Heartburn Products Calcium Carbonate with Magnesium Hydroxide Manufacturer
2008-08-13 Heart risks with calcium supplements in healthy post-menopausal women Calcium Citrate MediGuard CRT
2008-08-13 Heart risks with calcium supplements in healthy post-menopausal women MediGuard CRT
2008-08-13 Heart risks with calcium supplements in healthy post-menopausal women MediGuard CRT
2008-08-13 Heart risks with calcium supplements in healthy post-menopausal women MediGuard CRT
2015-05-27 FDA Warns About Possible New Side Effect of SGLT2 Inhibitors Canagliflozin / Metformin FDA
2008-08-12 Angioedema and ACE inhibitors Captopril MediGuard CRT
2008-08-12 Angioedema and ACE inhibitors Captopril and Hydrochlorothiazide MediGuard CRT
2008-01-31 Increased risk of suicidal thoughts and behaviour Carbamazepine FDA
2008-12-17 New FDA Warning on Seizure Medications Carbamazepine FDA
2009-05-06 FDA Approves Updated Labeling For Antiepileptic Medications Carbamazepine FDA
Back to Consumer Med Safety